Biotechnology - Biotechnology, Research

Filter

Current filters:

BiotechnologyResearch

Popular Filters

1 to 25 of 954 results

AstraZeneca to employ CRISPR, a new technique for drug discovery

AstraZeneca to employ CRISPR, a new technique for drug discovery

29-01-2015

Anglo-Swedish pharma major AstraZeneca has announced a research program to develop new medicines that…

AstraZenecaBiologyBiotechnologyResearchUK

Study shows Photocure's Hexvix significantly improves overall survival in bladder cancer

Study shows Photocure's Hexvix significantly improves overall survival in bladder cancer

29-01-2015

Photodynamic technology specialist Photocure has published data on a retrospective study showing Hexvix…

BiotechnologyHexvixOncologyPhotocureResearch

TxCell receives latest 1 million-euro milestone payment in OvaSave license agreement

TxCell receives latest 1 million-euro milestone payment in OvaSave license agreement

29-01-2015

French biotech company TxCell has received the latest 1 million-euro milestone payment ($1.13 million)…

BiotechnologyGastro-intestinalsLicensingOvaSaveResearchTxCell

AnaMar to focus on severe inflammation and fibrosis

28-01-2015

Swedish privately-held biopharma company AnaMar says it will focus pipeline development on severe inflammation…

AnaMarBiotechnologyInflammatory diseasesLicensingResearchRespiratory and Pulmonary

Tau-based vaccines could transform early Alzheimer’s treatment, says analyst

Tau-based vaccines could transform early Alzheimer’s treatment, says analyst

27-01-2015

While current treatments for Alzheimer’s disease are only able to ease symptoms temporarily, tau-based…

AC ImmuneBiotechnologycrenezumabEli LillygantenerumabJohnson & JohnsonMarkets & MarketingNeurologicalResearchRochesolanezumabVaccines

Innovation and confidence at JP Morgan conference, says Edison analyst

26-01-2015

The atmosphere at this year's annual JPMorgan Conference in San Francisco was understandably buoyant,…

BiotechnologyFinancialMergers & AcquisitionsResearch

Kite Pharma expands CAR-T deal with Sourasky Medical Center

26-01-2015

US clinical-stage biopharma company Kite Pharma, focused on developing engineered autologous T cell therapy…

BiotechnologyKite PharmaOncologyResearch

Not for the faint of CAR-T: The CAR-T therapy landscape in 2015

22-01-2015

A new report shows investor enthusiasm for cancer-fighting CAR-T therapies is likely to continue despite…

BiotechnologyJuno TherapeuticsKite PharmaOncologyResearch

BIO responds to President Obama's State of the Union speech

22-01-2015

In his State of the Union speech to the American public this week, US President Barak Obama said that…

BiotechnologyPoliticsResearchUSA

Syncona and UCL Business form cancer immunotherapy company Autolus

Syncona and UCL Business form cancer immunotherapy company Autolus

22-01-2015

Investment company Syncona and UCL Business, the wholly-owned technology transfer company of University…

BiologyBiotechnologyOncologyResearchUK

FDA removes hold on CytRx's aldoxorubicin Phase III trials

FDA removes hold on CytRx's aldoxorubicin Phase III trials

20-01-2015

The US Food and Drug Administration has removed the partial clinical hold on biopharma oncology company…

aldoxorubicinBiotechnologyCytRxOncologyRegulationResearchUSA

Solasia Pharma and Meiji Seika Pharma collaborate on darinaparsin

19-01-2015

Privately-held Solasia Pharma and fellow Japanese drugmaker Meiji Seika Pharma have entered into a license…

BiotechnologydarinaparsinJapanLicensingMeiji Seika PharmaOncologyResearchSolasia PharmaZiopharm Oncology

Cellectis links with Ohio State University on multiple myeloma technology

16-01-2015

France-based genome engineering specialist Cellectis has entered into an exclusive license agreement…

BiotechnologyCD123CD38CellectisCS1LicensingOncologyResearch

Amgen trials show no differences in quality of life between the FOLFOX regimens with or without Vectibix

Amgen trials show no differences in quality of life between the FOLFOX regimens with or without Vectibix

16-01-2015

USA-based Amgen, the world’s leading independent biotech firm, says that Phase II and Phase III studies…

AmgenBiotechnologyOncologyResearchVectibix

Novogen identifies family of compounds to promote brain stem cell growth

Novogen identifies family of compounds to promote brain stem cell growth

16-01-2015

Australian biotech firm Novogen has announced an important discovery in its regenerative medicine program…

BiotechnologyNeurologicalNovogenResearch

Treeway collaborates with uniQure on gene therapy for ALS

15-01-2015

Netherlands-based biotech firm Treeway has entered into a collaboration with Dutch gene therapy company…

BiotechnologyLicensingNeurologicalResearchTreewayuniQure

New biotech Solvanix launched in Australia with start-up investment from the MRCF

15-01-2015

Solvanix Pty Ltd, an early stage biotechnology company with a novel technology for improving stability…

AustraliaBiotechnologyFinancialResearchSolvanixStAbilize

Merck & Co inks discovery and development deal with Moderna

Merck & Co inks discovery and development deal with Moderna

13-01-2015

Privately-held Moderna Therapeutics has entered into a license and collaboration agreement with US pharma…

Anti-viralsBiotechnologyFinancialMerck & CoModerna TherapeuticsResearchUSAVaccines

Vedanta collaborates with Janssen on IBD drug candidate VE202

13-01-2015

US microbiome company Vedanta Biosciences has signed a license agreement with Janssen Biotech for Vedanta's…

BiotechnologyGastro-intestinalsJanssen BiotechJohnson & JohnsonLicensingResearchVE202Vedanta Biosciences

Amgen to collaborate with University of Texas on BiTE technology

Amgen to collaborate with University of Texas on BiTE technology

13-01-2015

US biotech major Amgen is to collaborate with the MD Anderson Cancer Center at the University of Texas…

AmgenBiotechnologyOncologyResearchUSA

Sanofi and Regeneron’s alirocumab meets endpoints in cholesterol study

Sanofi and Regeneron’s alirocumab meets endpoints in cholesterol study

09-01-2015

French pharma major Sanofi and Regeneron Pharmaceuticals today announced that two new ODYSSEY trials,…

alirocumabBiotechnologyCardio-vascularRegeneron PharmaceuticalsResearchSanofi

Biogen Idec reports positive results from Phase II trial of anti-LINGO-1 in acute optic neuritis

Biogen Idec reports positive results from Phase II trial of anti-LINGO-1 in acute optic neuritis

09-01-2015

US biotech firm Biogen Idec has announced positive top-line results from its Phase II trial of anti-LINGO-1…

anti-LINGO-1Biogen IdecBiotechnologyOphthalmicsResearchUSA

Alkermes rises on positive ALKS 5461 results

07-01-2015

Shares of Ireland-headquartered biotech firm Alkermes closed up 2.6% to $60.93, having risen as much…

AlkermesALKS 5461BiotechnologyNeurologicalResearch

23andMe and Genentech in deal to analyze genomic data for Parkinson's disease

06-01-2015

23andMe, the leading personal genetics company, and Genentech, a subsidiary of Swiss pharma giant Roche,…

23andMeBiotechnologyGenentechNeurologicalResearchRoche

1 to 25 of 954 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top